Novo Nordisk (NVO) plans to launch its blockbuster weight-loss drug Wegovy in vial format. The move targets customers who have shifted to rival Eli Lilly & Co. (LLY).
This packaging change follows Eli Lilly’s lead in offering similar options for obesity treatments. Novo Nordisk currently distributes Wegovy exclusively through plastic injector pens.
The update aims to broaden accessibility and boost competitiveness in the growing market for weight management drugs.
Britain’s energy regulator Ofgem delivers practical advice to help households lower gas and electricity expenses. Forecasts predict the energy price…
Man Lives in Fear After Online Mob Targets Him WronglyA 32-year-old store manager from a small Ohio town faces ongoing…
Community West Bancshares, the holding company for Community West Bank, recently presented its strategic outlook and financial performance at the…
Coroner Probes Mysterious Quadruple Death in Coastal Community A coroner's investigation opened Monday into the June 2023 deaths of four…
